Evolution of HIV and HCV coinfected children receiving long-term lopinavir/ritonavir-based antiretroviral therapy

被引：0
作者：
Larru, Beatriz [1 ]
Resino, Salvador [1 ,2 ]
Bellon, Jose M. [1 ]
Isabel de Jose Gomez, M. [3 ]
Fortuna, Claudia [4 ]
Munoz-Fernandez, M. Angeles [1 ]
机构：
[1] Hosp Gen Univ Gregorio Maranon, Lab Inmunobiol Mol, Madrid 28007, Spain
[2] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain
[3] Hosp Univ La Paz, Serv Inmunopediat, Madrid, Spain
[4] Hosp San Joan de Deu, Serv Inmunopediat, Barcelona, Spain
来源：
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA | 2008年 / 26卷 / 07期
关键词：
HIV; HCV; LPV/r; HAART; children;
D O I：
10.1157/13125640
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
INTRODUCTION. There are few studies investigating the effect of HCV coinfection on HIV-related disease among children. METHODS. We studied 5 HIV/HCV coinfected children receiving an LPV/r-containing HAART regimen. Their evolution was compared with a control group of 72 HIV-infected children. RESULTS. All 5 HIV/HCV-coinfected children achieved sustained immune recovery during the study. Moreover, they showed better viral suppression than the control group. None of the 5 HIV/HCV-coinfected children experienced any adverse effects with the use of LPV/r. CONCLUSION. HIV/HCV coinfection does not reduce the benefits obtained from HAART.
引用
收藏
页码：426 / 429
页数：4
相关论文
共 50 条
  • [31] Immune Reconstitution in HIV plus Subjects on Lopinavir/Ritonavir-Based HAART According to the Severity of Pre-Therapy CD4+
    Marchetti, Giulia
    Merlini, Esther
    Sinigaglia, Elisabetta
    Iannotti, Nathalie
    Bai, Francesca
    Savoldi, Alessia
    Tincati, Camilla
    Carpani, Giovanni
    Bini, Teresa
    Monforte, Antonella d'Arminio
    CURRENT HIV RESEARCH, 2012, 10 (07) : 597 - 605
  • [32] Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy
    Kaufmann, GR
    Bloch, M
    Zaunders, JJ
    Smith, D
    Cooper, DA
    AIDS, 2000, 14 (08) : 959 - 969
  • [33] Estradiol Levels Are Altered in Human Immunodeficiency Virus-Infected Pregnant Women Randomized to Efavirenz-Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy
    McDonald, Chloe R.
    Conroy, Andrea L.
    Gamble, Joel L.
    Papp, Eszter
    Hawkes, Michael
    Olwoch, Peter
    Natureeba, Paul
    Kamya, Moses
    Silverman, Michael
    Cohan, Deborah
    Koss, Catherine A.
    Dorsey, Grant
    Kain, Kevin C.
    Serghides, Lena
    CLINICAL INFECTIOUS DISEASES, 2018, 66 (03) : 428 - 436
  • [34] Long-Term Medication Adherence in Patients Receiving Antiretroviral Drug Therapy
    Preininger, Lee
    Cantwell-McNelis, Kelly
    James, Christopher
    Sullivan, Mary Catherine
    Szabo, Susan
    Bincsik, Arlene
    CURRENT HIV RESEARCH, 2011, 9 (04) : 253 - 255
  • [35] Hepatic, Renal, Hematologic, and Inflammatory Markers in HIV-Infected Children on Long-term Suppressive Antiretroviral Therapy
    Melvin, Ann J.
    Warshaw, Meredith
    Compagnucci, Alexandra
    Saidi, Yacine
    Harrison, Linda
    Turkova, Anna
    Tudor-Williams, Gareth
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2017, 6 (03) : E109 - E115
  • [36] Long-term survival outcomes of HIV infected children receiving antiretroviral therapy: an observational study from Zambia (2003-2015)
    Mutanga, Jane N.
    Mutembo, Simon
    Ezeamama, Amara E.
    Song, Xiao
    Fubisha, Robert C.
    Mutesu-Kapembwa, Kunda
    Sialondwe, Derrick
    Simuchembu, Brenda
    Chinyonga, Jelita
    Thuma, Philip E.
    Whalen, Christopher C.
    BMC PUBLIC HEALTH, 2019, 19 (1)
  • [37] Sustained Long-Term Decline in Anti-HCV Neutralizing Antibodies in HIV/HCV-Coinfected Patients Five Years after HCV Therapy: A Retrospective Study
    Sepulveda-Crespo, Daniel
    Volpi, Camilla
    Amigot-Sanchez, Rafael
    Yelamos, Maria Belen
    Diez, Cristina
    Gomez, Julian
    Hontanon, Victor
    Berenguer, Juan
    Gonzalez-Garcia, Juan
    Martin-Escolano, Ruben
    Resino, Salvador
    Martinez, Isidoro
    PHARMACEUTICALS, 2024, 17 (09)
  • [38] Long-term response to combination antiretroviral therapy in HIV-infected children in the Netherlands registered from 1996 to 2012
    Cohen, Sophie
    Smit, Colette
    van Rossum, Annemarie M. C.
    Fraaij, Pieter L. A.
    Wolfs, Tom F. W.
    Geelen, Sibyl P. M.
    Schoelvinck, Elisabeth H.
    Warris, Adilia
    Scherpbier, Henriette J.
    Pajkrt, Dasja
    AIDS, 2013, 27 (16) : 2567 - 2575
  • [39] Long-term evolution in liver disease markers and immune and lipid profiles in vertically HIV/HCV-coinfected youths with sustained viral response after direct-acting antivirals therapy
    Tarancon-Diez, Laura
    Carrasco, Itziar
    Ory, Santiago Jimenez de
    Sanchez, Arantxa Berzosa
    Hernanz-Lobo, Alicia
    Montero-Alonso, Marta
    Laguno, Montserrat
    Bernardino, Jose I.
    Lopez-Cortes, Luis
    Aldamiz-Echevarria, Teresa
    Collado, Pilar
    Bisbal, Otilia
    Samperiz, Gloria
    Gavilan, Cesar
    Jose Rios, M.
    Ibarra, Sofia
    Navarro, Maria Luisa
    Angeles Munoz-Fernandez, M.
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 162
  • [40] Does a significant reduction in malaria risk make lopinavir/ritonavir-based ART cost-effective for children with HIV in co-endemic, low-resource settings?
    Ahmed, Bilaal S.
    Phelps, B. Ryan
    Reuben, Elan B.
    Ferris, Robert E.
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2014, 108 (01) : 49 - 54
12345